Glenmark Pharmaceuticals Ltd. | Ownership
Companies that own Glenmark Pharmaceuticals Ltd.
Temasek Holdings Pte Ltd. (Investment Management)
11,261,010
3.99%
0
0.23%
06/30/2018
HDFC Asset Management Co. Ltd. (Invt Mgmt)
7,543,800
2.67%
0
0.36%
07/31/2018
Templeton Asset Management Ltd. (Hong Kong)
7,204,562
2.54%
120,141
0.41%
06/30/2018
The Vanguard Group, Inc.
4,907,687
1.74%
-42,697
0%
07/31/2018
HSBC Global Asset Management (Hong Kong) Ltd.
4,131,250
1.46%
1,224,917
0.44%
04/30/2018
BlackRock Fund Advisors
3,747,048
1.33%
-3,535
0%
09/06/2018
Life Insurance Corp. of India
3,688,999
1.31%
0
0.04%
06/30/2018
Templeton Asset Management Ltd.
2,932,034
1.04%
671,596
0.93%
06/30/2018
General Insurance Corp. of India (Invt Port)
2,350,000
0.83%
-250,000
0.51%
03/31/2017
Dimensional Fund Advisors LP
1,603,318
0.56%
177,341
0%
04/30/2018
| Address |
Glenmark House, HDO Corporate Bldg
Mumbai Maharashtra 400099
India
|
|
Employees
|
- |
| Website |
http://www.glenmarkpharma.com |
| Updated |
09/14/2018 |
| Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India. |
